Winrevair

Pharma

Merck set to advance Winrevair to phase 3 in new indication

Results from a proof-of-concept study of Merck’s Winrevair pave the way for further study of the activin signaling inhibitor in the potential new use.

Kevin Dunleavy Nov 18, 2025 11:22am

Merck nabs updated FDA label for PAH med Winrevair

Oct 27, 2025 11:37am

Merck releases results from successful trial of Winrevair

Sep 30, 2025 8:00am

Merck's Winrevair cuts death, morbidity risk by 76%

Mar 31, 2025 10:00am

Merck halts Gardasil shipments to China, pulls $11B sales target

Feb 4, 2025 12:10pm

After trial success, Merck halts a different Winrevair study

Jan 30, 2025 6:45am